| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.2 |